255 results on '"Mirabel, X."'
Search Results
2. Radiotherapy for cancers of the oesophagus, cardia and stomach
3. Adjuvant management of operated uterine sarcomas: A single institution experience
4. Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
5. EARLY STAGE CERVICAL CANCER TREATED BY PREOPERATIVE BRACHYTHERAPY: PROGNOSTIC FACTORS ANS CLINICAL OUTCOMES: EP257
6. CT appearance of pulmonary carcinomas after stereotactic radiation therapy
7. Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial
8. Results and special considerations when treating elderly patients with CyberKnife ®: A review of 345 cases
9. Vismodegib induces significant clinical response in locally advanced trichoblastic carcinoma
10. 887P Antitumor activity of the radioenhancer NBTXR3 on injected lesions to estimate overall survival: Exploratory analyses from a phase I in cisplatin-ineligible locally advanced HNSCC patients
11. Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial
12. Acute respiratory disease syndrome with preoperative chronomodulated chemoradiotherapy in patients with esophageal cancer. Early termination of a phase I trial
13. MO-0311 Radiotherapy-related CIEDs dysfunctions in the Lille University Hospital remote monitored patients
14. PO-1237 Efficacy and tolerance of stereotactic re-irradiation in the treatment of head and neck cancers
15. Photodynamic therapy for early oesophageal cancer
16. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma
17. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study
18. SIOG2021-0035 - A phase I dose expansion study of NBTXR3, radiation enhancing hafnium oxide nanoparticles, for the treatment of cisplatin-ineligible locally advanced HNSCC patients
19. Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients
20. NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Cisplatin-Ineligible Patients With Locally Advanced HNSCC: A Phase I Trial
21. Hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy for the treatment of frail and/or elderly patients with locally advanced HNSCC: a phase I/II study
22. Workflow optimization for robotic stereotactic radiotherapy treatments: Application of Constant Work In Progress workflow
23. NBTXR3 for the Treatment of Elderly Frail Patients with Locally Advanced HNSCC
24. Intracavitary Preoperative Brachytherapy Followed By Whertheim-Type Hysterectomy in Localized Cervical Cancer: Clinical Data and Toxicity Results from a Single Institution Experience
25. EP-1897 Texture analysis of the initial CT to predict the response to neoadjuvant CRT in rectal cancer
26. EP-1257 Post-operative hypo-fractionated SBRT in a large series of patients with brain metastases
27. OC-043 HNSCC in elderly frail patients treated by hafnium oxide nanoparticles activated by IMRT
28. Elderly Patients: NBTXR3 as a Novel Treatment Option in Locally Advanced HNSCC
29. 1058P - Elderly patients with locally advanced head and neck squamous cell carcinoma treated with NBTXR3 nanoparticles activated by radiotherapy: A phase I trial
30. Hafnium Oxide Nanoparticles as a Promising Emergent Treatment for Head And Neck Cancer
31. EP-2144: Tumor and OAR delineation variation – Dice coefficient versus dose assessed with automated planning
32. PO-0793: Metformin with neoadjuvant chemoradiotherapy in the management of locally advanced rectal cancer
33. PO-0742: Intensity-modulated radiotherapy for the adjuvant treatment of breast cancer: a prospective study
34. PV-0105: Stereotactic body radiotherapy treatment for hepatocellular carcinoma: A phase II study
35. Chest Magnetic Resonance Imaging Decreases Inter-observer Variability of Gross Target Volume for Lung Tumors
36. EP-1093: Hypofractioned robotic stereotactic radiotherapy of Head and neck Paragangliomas
37. PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers
38. OC-0541: Automated treatment planning for prospective QA in the TRENDY randomized trial on liver-SBRT for HCC
39. French updated recommendations in Stage I to III melanoma treatment and management.
40. Clinical implementation of a Monte Carlo based treatment plan QA platform for validation of Cyberknife and Tomotherapy treatments.
41. 1155P - VISMONEO - a phase II study assessing vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma - Patients characteristics
42. 657P - Esophageal adenocarcinoma: Impact of a large hiatal hernia on outcomes after surgery
43. Interstitial Brachytherapy (IBT) BOOST in the Treatment of Cancers of the Anal Canal
44. Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients).
45. Low-Dose-Rate (LDR) Interstitial Brachytherapy (BT) for Early-Stage Penile Cancer: 20-Year Single-Institution Experience on 76 Patients
46. PO-0795: Implementing the Monte Carlo algorithm in lung SBRT: clinical outcome on 205 patients
47. EP-1394: Fractionated stereotactic radiation with CyberKnifeÆ for uveal melanoma : early results.
48. Evaluating Small Bowel Dose–Volume Tolerance Limits for SBRT Using a Preoperative Rectal Radiation Therapy Model: Are We Setting the Bar Too High?
49. EP-1246: Tracking of hepatic lesions: Correlation between the movements of target and fiducials during breathing cycle
50. SP-0011: SBRT for oligometastatic disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.